GRIFOLS SA INH. A EO-,25/ ES0171996087 /
| 2024-06-11 8:03:13 AM | Chg. -0.114 | Volume | Bid8:26:13 PM | Ask8:26:13 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 9.172EUR | -1.23% | 0 Turnover: 0.000 |
9.020Bid Size: 500 | 9.158Ask Size: 500 | 7.46 bill.EUR | - | 100.20 |
GlobeNewswire
04-18
Grifols Celebrates 50 Years of Manufacturing Life-Changing Plasma-Derived Medicines for Patients at ...
GlobeNewswire
04-04
Grifols Procleix ArboPlex Assay® Receives CE Mark, the First and Only 4-in-1 NAT for Arbovirus Scree...
GlobeNewswire
2023-11-15
Grifols Completes Cohort 1 in Clinical Study of Alpha-1 15%, Evaluating First-in-Human Subcutaneous ...
